- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Page 132
Mitsui enters Arcadia in $30m series C
Arcadia, the operator of a clean energy-sourcing platform for domestic use, boosted its overall equity funding to more than $62m in a Mitsui USA-backed round.
Dec 11, 2019Imperative Care impresses with $79m
Ascension Ventures was among the participants in the first close of neurovascular catheter developer Imperative Care's series C round, which it expects to close at $85m.
Dec 11, 2019LandSpace embraces $71m
Space rocket producer LandSpace, a Tsinghua University spinout, has now raised about $200m in all from investors including Xidian University and 36kr Media.
Dec 11, 2019Zentalis zips to $85m series C
Pharmaron-backed Zentalis Pharmaceuticals has now secured $147m altogether and will advance its breast cancer and solid tumour candidates through clinical trials.
Dec 10, 2019Ribo rips into series C1 round
Legend Capital returned as the RNA drug developer secured $28.8m in a round co-led by Panlin Capital and Trinity Innovation Fund.
Dec 9, 2019Nutriati heats up with series C funding
PLT Health Solutions and existing backer Tate & Lyle Ventures contributed to a $12.7m round for vegan ingredients supplier Nutriati to take its total funding to more than $22m.
Dec 9, 2019Corporate venturing deal net: 2-6 December 2019
Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds
Dec 6, 2019Roche polishes Black Diamond's $85m series C
The cancer drug developer emerged from stealth with $194m in funding, $85m of which was just closed in a round featuring returning investor Roche Venture Fund.
Dec 6, 2019Figure finds $103m in series C round
MUFG Innovation Partners contributed to a round that boosted the valuation of the blockchain-based lending platform to $1.2bn.
Dec 6, 2019Roche polishes Black Diamond's $85m series C
The cancer drug developer emerged from stealth with $194m in funding, $85m of which was just closed in a round featuring returning investor Roche Venture Fund.
Dec 6, 2019About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


